Drug intelligence / Profile preview

cinepazet

Development stage
Discontinued
Lead developer
Sanofi
Modality
Small Molecules
01

Overview

Cinepazet is a small molecule vasodilator and an ethyl ester derivative of cinepazic acid. It belongs to the class of alpha amino acid esters and features a piperazine ring with a trimethoxyphenyl group. Cinepazet acts primarily by inhibiting the influx of extracellular calcium into cells through slow calcium channels in the cell membrane. This mechanism leads to vasodilation and has been used for the treatment of angina pectoris and other cardiovascular conditions. The drug was marketed in France and Italy under the brand name Vascoril during the 1970s for cardiac therapy[9][10][7][5]. Its primary indication is as an antianginal agent.

Brand names
Vascoril
Other names
ethyl (4-(3-(3,4,5-trimethoxyphenyl)acryloyl)-1-piperazinyl)acetate4-[3-(3,4,5-trimethoxyphenyl)-acryloyl]-piperazin-1-yl-acetic acid ethyl ester1-piperazineacetic acid, 4-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propen-1-yl]-, ethyl estercinepazic acid ethyl esterethyl cinepazate
02

Targets

LTCC (Voltage-gated calcium channel (L-type))

Beyond the preview

Go deeper on cinepazet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cinepazet.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call